Avacta Affimer Innovative Immunotherapies Presentation Feb 2019
Motif Bio plc FDA cannot approve the NDA
Utilitywise plc No return to Shareholders
Anglo Pacific Group PLC Kestrel operator plans to significantly increase volumes in 2019
Bushveld Minerals Limited Key milestone achieved completion and review of the Bankable Feasibility Study Imaloto Project
AB Dynamics plc Directorate Change
Oncimmune Holdings plc New Management Structure, Forward Strategy and Maximising Additional Opportunities
Norman Broadbent plc Revenues increase 40%
DirectorsTalk Interviews LSE London Stock Exchange PLC Company Interviews
Q & A’s
Request an Interview
Reports / Research
UK Broker Ratings
USA Broker Ratings
Hardman & Co
FTSE 100 Companies
DOW 30 Companies
Share Price Alerts
Terms of Service
Page 30 of 108
© 2019 - DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
Are you sure?
Please confirm deletion. There is no undo!